Fiche du document
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2007.10.042
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/18022360
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/0092-8674
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_56A2357113573
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Proteids Papers Cell degeneration Carcinoma Cancers Malignancy (Cancer) Malignant tumorsCiter ce document
H. Wu et al., « Smac Mimetics and TNFalpha: A Dangerous Liaison? », Serveur académique Lausannois, ID : 10.1016/j.cell.2007.10.042
Métriques
Partage / Export
Résumé
Inhibitor of apoptosis proteins (IAPs) such as XIAP, cIAP1, and cIAP2 are upregulated in many cancer cells. It has been thought that small-molecule mimetics of Smac, an endogenous IAP antagonist, might potentiate apoptosis in cancer cells by promoting caspase activation. However, three recent papers, two in Cell (Vince et al., 2007; Varfolomeev et al., 2007) and one in Cancer Cell (Petersen et al., 2007), now report that Smac mimetics primarily kill cancer cells via a different mechanism, the induction of autoubiquitination and degradation of cIAPs, which culminates in TNFalpha-mediated cell death.